Search hospitals > South Carolina > Spartanburg

Spartanburg Medical Center

Claim this profile
Spartanburg, South Carolina 29303
Global Leader in Parotid Gland Cancer
Global Leader in Breast Cancer
Conducts research for Lung Cancer
Conducts research for Cervical Adenocarcinoma
Conducts research for Cancer
319 reported clinical trials
15 medical researchers
Photo of Spartanburg Medical Center in SpartanburgPhoto of Spartanburg Medical Center in SpartanburgPhoto of Spartanburg Medical Center in Spartanburg

Summary

Spartanburg Medical Center is a medical facility located in Spartanburg, South Carolina. This center is recognized for care of Parotid Gland Cancer, Breast Cancer, Lung Cancer, Cervical Adenocarcinoma, Cancer and other specialties. Spartanburg Medical Center is involved with conducting 319 clinical trials across 461 conditions. There are 15 research doctors associated with this hospital, such as Michael Humeniuk, Amarinthia (Amy) Curtis, Vikas Dembla, and Jeremy M. Kilburn.

Area of expertise

1Parotid Gland Cancer
Global Leader
Spartanburg Medical Center has run 98 trials for Parotid Gland Cancer. Some of their research focus areas include:
Stage IV
Stage III
Stage II
2Breast Cancer
Global Leader
Spartanburg Medical Center has run 63 trials for Breast Cancer. Some of their research focus areas include:
HER2 negative
ER positive
Stage IV

Top PIs

Clinical Trials running at Spartanburg Medical Center

Breast Cancer
Lung Cancer
Small Cell Lung Cancer
Parotid Gland Cancer
Non-Small Cell Lung Cancer
Cancer
Melanoma
Prostate Cancer
Testicular cancer
Breast cancer
Image of trial facility.

Chemotherapy + Hormone Therapy

for Breast Cancer

This trial is testing if adding additional cancer-fighting drugs to treatments that stop certain body functions is better than just using the treatments that stop those functions alone. It targets younger women with early-stage breast cancer who have a higher risk of dying from the disease. The treatment works by stopping certain body functions and using drugs to kill cancer cells.
Recruiting2 awards Phase 319 criteria
Image of trial facility.

Sacituzumab Govitecan + Pembrolizumab

for Triple Negative Breast Cancer

The goal of this study is to find out if the experimental product, sacituzumab govitecan-hziy (SG) in combination with pembrolizumab given after surgery, is effective and safe compared to the treatment of physician's choice (TPC) which includes either pembrolizumab or pembrolizumab plus capecitabine in participants with triple negative breast cancer that still remains after surgery and pre-surgical treatment.
Recruiting2 awards Phase 36 criteria
Image of trial facility.

Omitting Radiation Therapy

for Breast Cancer

The purpose of this study is to compare the effects on low risk breast cancer receiving usual care that includes regional radiation therapy, with receiving no regional radiation therapy. Researchers want to see if not giving this type of radiation treatment works as well at preventing breast cancer from coming back.
Recruiting2 awards Phase 319 criteria

Similar Hospitals nearby

Frequently asked questions

What kind of research happens at Spartanburg Medical Center?
Where is Spartanburg Medical Center located?
Who should I call to ask about financial aid or insurance network?
What insurance does Spartanburg Medical Center accept?
What awards or recognition has Spartanburg Medical Center received?
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security